Related Experiment Video
Updated: Nov 4, 2025
Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
Published on: March 15, 2024
Targeting ferroptosis in pancreatic cancer: a double-edged sword
Xin Chen1, Rui Kang2, Guido Kroemer3
1Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation, The Third Affiliated Hospital, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, China; Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, China; Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Abstract:
Pancreatic ductal adenocarcinoma (PDAC) remains an aggressive malignancy with a 5-year survival rate below 10%. Its unique genetic makeup and tumor microenvironment produce a lack of response to current treatments, including chemotherapy, radiotherapy, and immunotherapy. Recent preclinical studies have revealed that ferroptosis, an iron-dependent form of nonapoptotic cell death driven by unrestricted lipid peroxidation, may be an attractive therapeutic goal in PDAC. Understanding the dual role of ferroptotic cell death in both promoting and suppressing tumor immunity, as well as its integrated regulatory mechanisms and signaling pathways, may lead to more effective treatment designs for clinical trials of PDAC and may minimize or delay the emergence of drug resistance or side effects.
Insights
Pancreatic cancer (PDAC) is aggressive and resistant to current therapies. Ferroptosis, a cell death pathway, shows promise as a new therapeutic target for PDAC, potentially improving treatment outcomes.
Area of Science:
- Oncology
- Cell Biology
- Cancer Therapeutics
Background:
- Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive cancer with poor survival rates.
- PDAC exhibits resistance to conventional treatments like chemotherapy, radiotherapy, and immunotherapy.
- The tumor microenvironment and unique genetics of PDAC contribute to treatment unresponsiveness.
Purpose of the Study:
- To explore ferroptosis as a potential therapeutic strategy for PDAC.
- To understand the dual role of ferroptosis in tumor immunity (promoting and suppressing).
- To elucidate the regulatory mechanisms and signaling pathways of ferroptosis in PDAC.
Main Methods:
- Review of preclinical studies on ferroptosis in PDAC.
- Analysis of the impact of ferroptosis on tumor immunity.
- Investigation of signaling pathways regulating ferroptosis.
Main Results:
- Ferroptosis, an iron-dependent cell death, is driven by lipid peroxidation.
- Ferroptosis has a complex role in modulating anti-tumor immunity.
- Understanding ferroptosis mechanisms may reveal new therapeutic avenues.
Conclusions:
- Ferroptosis presents a promising therapeutic target for pancreatic cancer.
- Further research into ferroptosis pathways can optimize PDAC treatment strategies.
- Targeting ferroptosis may overcome resistance and reduce side effects in PDAC therapy.
